Moreover, these molecules have been demonstrated to inhibit the infiltration of TCD3+ cells and CD68+ macrophages in the intestinal mucosa, thereby alleviating colitis by reducing the production of pro-inflammatory cytokines TNF-α and IL6 by macrophages (Du et al., 2019). The gene discussed is IL6; the disease is colitis.